Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13.76	7.64	114.14	72.31	119.82
Short-Term Investments	52.24	56.95	0	70	0
Cash & Cash Equivalents	66	64.59	114.14	142.31	119.82
Cash Growth	2.20%	-43.42%	-19.79%	18.77%	39.36%
Receivables	3.21	0.88	0.13	0.22	0.26
Other Current Assets	3.82	6.34	4.66	6.15	2.42
Total Current Assets	73.03	71.8	118.92	148.69	122.5
Property, Plant & Equipment	2.19	2.68	0.93	1.29	0.93
Total Long-Term Assets	2.19	2.68	0.93	1.29	0.93
Total Assets	75.23	74.48	119.85	149.97	123.43
Accounts Payable	6.68	5.64	6.55	5.91	8
Current Debt	0.55	0.5	0.22	0.25	0.33
Total Current Liabilities	7.23	6.14	6.78	6.16	8.33
Long-Term Debt	51.23	2	0.47	0.7	0.18
Total Long-Term Liabilities	51.23	2	0.47	0.7	0.18
Total Liabilities	58.46	8.14	7.25	6.86	8.51
Total Debt	51.78	2.49	0.7	0.94	0.51
Debt Growth	1978.48%	256.88%	-25.82%	83.07%	-
Retained Earnings	-326.03	-266.34	-207.95	-163.47	-113.5
Comprehensive Income	0	0	0	-1.63	-1.63
Shareholders' Equity	16.77	66.35	112.6	143.12	114.92
Net Cash / Debt	14.23	62.09	113.44	141.37	119.3
Net Cash / Debt Growth	-77.09%	-45.26%	-19.75%	18.49%	38.76%
Net Cash Per Share	0.33	1.46	2.71	4.82	7.56
Working Capital	65.81	65.66	112.15	142.53	114.17
Book Value Per Share	0.39	1.56	2.69	4.88	7.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).